Krzysztof Selmaj

35.4k citations
349 papers · 18.6k · 7 hit papers · h-index 63

Impact in

Papers in

Krzysztof Selmaj

330 papers receiving 18.0k citations

Krzysztof Selmaj's Hit Papers

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis 2022 · 127 citations
1270+12+25Years since publication50010001.5k2.0k

Peers

Krzysztof Selmaj
Comparison fields: 5 of 146
  • Pathology and Forensic Medicine 9.3k
  • Neurology 2.2k
  • Developmental Neuroscience 1.0k
  • Immunology 4.8k
  • Neurology 2.7k
Replace Scott S. Zamvil with:
Scott S. Zamvil United States
Reinhard Hohlfeld Germany
Amit Bar‐Or Canada
Michael K. Racke United States
Paul van der Valk Netherlands
Olaf Stüve United States
Jorge R. Oksenberg United States
Francesca Aloisi Italy
Eva Havrdová Czechia
Sergio E. Baranzini United States
Krzysztof Selmaj relative to Scott S. Zamvil United States Scott S. Zamvil's profile →
Citations per field
00.5×1.5×1.9×
Scott S. Zamvil · 1×
Citations per year

Countries citing papers authored by Krzysztof Selmaj

Since Specialization
Citations

This map shows the geographic impact of Krzysztof Selmaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krzysztof Selmaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krzysztof Selmaj more than expected).

Fields of papers citing papers by Krzysztof Selmaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krzysztof Selmaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krzysztof Selmaj. The network helps show where Krzysztof Selmaj may publish in the future.

Co-authors

The 25 scholars most cited alongside Krzysztof Selmaj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Krzysztof Selmaj Line = papers co-authored together Krzysztof Selmaj links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 349 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Hit paper breakdown →
20102041
2
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Hit paper breakdown →
20121391
3
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Hit paper breakdown →
19881252
4
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Hit paper breakdown →
2012932
5
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Hit paper breakdown →
2012928
6
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Hit paper breakdown →
1991665
7 1990496
8 1991407
9 1991404
10 1991248
11 2013227
12 2008222
13 2017219
14 2004217
15 2019212
16 2015211
17 2019206
18 2012199
19 2013190
20 1988183

About Krzysztof Selmaj

Krzysztof Selmaj is a scholar working on Pathology and Forensic Medicine, Immunology, Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 349 papers that have together received 18.6k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (169 papers), Immunotherapy and Immune Responses (39 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), Polyomavirus and related diseases (19 papers), Heat shock proteins research (16 papers), Peripheral Neuropathies and Disorders (15 papers), MicroRNA in disease regulation (14 papers) and T-cell and B-cell Immunology (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (9.3k citations), Neurology (2.2k citations), Developmental Neuroscience (1.0k citations), Immunology (4.8k citations) and Neurology (2.7k citations). Krzysztof Selmaj has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Cedric S. Raine, Celia F. Brosnan, Ludwig Kappos, Douglas L. Arnold, Eva Havrdová, Marcin P. Mycko, Ernst‐Wilhelm Radue, Ralf Gold, Amit Bar‐Or and Lixin Zhang-Auberson. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Journal of Neuroimmunology, Multiple Sclerosis and Related Disorders and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact